SITAGLIVAC GM1/1000

SITAGLIVAC GM1/1000 Tablets combine Glimepiride 1 mg, Sitagliptin 50 mg, and Metformin Hydrochloride 1000 mg to provide comprehensive management of Type 2 Diabetes Mellitus. This triple-action formulation helps improve blood glucose control by enhancing insulin secretion, reducing glucose production in the liver, improving insulin sensitivity, and increasing the body's natural incretin activity.

SITAGLIVAC GM1/1000 is recommended for patients whose blood sugar levels are not adequately controlled with diet, exercise, or dual-drug therapy. It helps achieve better glycaemic control and reduces the risk of long-term diabetes-related complications.

Key Benefits

• Effectively controls blood glucose levels in Type 2 Diabetes
• Enhances insulin secretion when blood sugar levels are elevated
• Reduces glucose production by the liver
• Improves insulin sensitivity and glucose utilization
• Supports long-term glycaemic control
• Helps reduce the risk of diabetes-related complications when combined with a healthy lifestyle